Literature DB >> 23044305

Extensive contact tracing and screening to control the spread of vancomycin-resistant Enterococcus faecium ST414 in Hong Kong.

Vincent Chi-Chung Cheng1, Josepha Wai-Ming Tai, Modissa Lai-Ming Ng, Jasper Fuk-Woo Chan, Sally Cheuk-Ying Wong, Iris Wai-Sum Li, Hon-Ping Chung, Wai-Kei Lo, Kwok-Yung Yuen, Pak-Leung Ho.   

Abstract

BACKGROUND: Proactive infection control management is crucial in preventing the introduction of multiple drug resistant organisms in the healthcare setting. In Hong Kong, where vancomycin-resistant enterococci (VRE) endemicity is not yet established, contact tracing and screening, together with other infection control measures are essential in limiting intra- and inter-hospital transmission. The objective of this study was to illustrate the control measures used to eradicate a VRE outbreak in a hospital network in Hong Kong.
METHODS: We described an outbreak of VRE in a healthcare region in Hong Kong, involving a University affiliated hospital and a convalescent hospital of 1600 and 550 beds respectively. Computer-assisted analysis was utilized to facilitate contact tracing, followed by VRE screening using chromogenic agar. Multi-locus sequence typing (MLST) was performed to assess the clonality of the VRE strains isolated. A case-control study was conducted to identify the risk factors for nosocomial acquisition of VRE.
RESULTS: Between November 26 and December 17, 2011, 11 patients (1 exogenous case and 10 secondary cases) in two hospitals with VRE colonization were detected during our outbreak investigation and screening for 361 contact patients, resulting in a clinical attack rate of 2.8% (10/361). There were 8 males and 3 females with a median age of 78 years (range, 40 - 87 years). MLST confirmed sequence type ST414 in all isolates. Case-control analysis demonstrated that VRE positive cases had a significantly longer cumulative length of stay (P < 0.001), a higher proportion with chronic cerebral and cardiopulmonary conditions (P = 0.001), underlying malignancies (P < 0.001), and presence of urinary catheter (P < 0.001), wound or ulcer (P < 0.001), and a greater proportion of these patients were receiving β-lactam/β-lactamase inhibitors (P = 0.009), carbapenem group (P < 0.001), fluoroquinolones (P = 0.003), or vancomycin (P = 0.001) when compared with the controls.
CONCLUSION: Extensive contact tracing and screening with a "search-and-confine" strategy was a successful tool for outbreak control in our healthcare region.

Entities:  

Mesh:

Year:  2012        PMID: 23044305

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  9 in total

1.  Use of fluoroquinolones is the single most important risk factor for the high bacterial load in patients with nasal and gastrointestinal colonization by multidrug-resistant Acinetobacter baumannii.

Authors:  V C C Cheng; J H K Chen; S Y C So; S C Y Wong; M K Yan; P H Chau; W M Lee; K K W To; J F W Chan; I F N Hung; P L Ho; K Y Yuen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-15       Impact factor: 3.267

2.  Control of hospital endemicity of multiple-drug-resistant Acinetobacter baumannii ST457 with directly observed hand hygiene.

Authors:  V C C Cheng; J H K Chen; R W S Poon; W M Lee; S Y C So; S C Y Wong; P H Chau; C C Y Yip; S S Y Wong; J F W Chan; I F N Hung; P L Ho; K Y Yuen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-21       Impact factor: 3.267

3.  A mixed-methods study on toilet hygiene practices among Chinese in Hong Kong.

Authors:  Dan Wu; Tai Pong Lam; Hoi Yan Chan; Kwok Fai Lam; Xu Dong Zhou; Jia Yao Xu; Kai Sing Sun; Pak Leung Ho
Journal:  BMC Public Health       Date:  2019-12-10       Impact factor: 3.295

4.  National surveillance on vancomycin-resistant Enterococcus faecium in Taiwan: emergence and widespread of ST414 and a Tn1546-like element with simultaneous insertion of IS1251-like and IS1678.

Authors:  An-Jing Kuo; Lin-Hui Su; Jwu-Ching Shu; Jann-Tay Wang; Jen-Hsien Wang; Chang-Phone Fung; Ju-Hsin Chia; Jang-Jih Lu; Tsu-Lan Wu
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

5.  Effect of proactive infection control measures on benchmarked rate of hospital outbreaks: An analysis of public hospitals in Hong Kong over 5 years.

Authors:  Vincent C C Cheng; Josepha W M Tai; Lisa M W Wong; Radley H C Ching; Modissa M L Ng; Sara K Y Ho; Doris W Y Lee; W S Li; W M Lee; Siddharth Sridhar; Sally C Y Wong; P L Ho; K Y Yuen
Journal:  Am J Infect Control       Date:  2015-06-06       Impact factor: 2.918

Review 6.  Clinical management and infection control of SARS: lessons learned.

Authors:  Vincent C C Cheng; Jasper F W Chan; Kelvin K W To; K Y Yuen
Journal:  Antiviral Res       Date:  2013-08-28       Impact factor: 5.970

7.  Minimal intervention for controlling nosocomial transmission of methicillin-resistant staphylococcus aureus in resource limited setting with high endemicity.

Authors:  Vincent Chi-Chung Cheng; Josepha Wai-Ming Tai; Pui-Hing Chau; Jonathan Hon-Kwan Chen; Mei-Kum Yan; Simon Yung-Chun So; Kelvin Kai-Wang To; Jasper Fuk-Woo Chan; Sally Cheuk-Ying Wong; Pak-Leung Ho; Kwok-Yung Yuen
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

Review 8.  Decolonization of gastrointestinal carriage of vancomycin-resistant Enterococcus faecium: case series and review of literature.

Authors:  Vincent C C Cheng; Jonathan H K Chen; Josepha W M Tai; Sally C Y Wong; Rosana W S Poon; Ivan F N Hung; Kelvin K W To; Jasper F W Chan; Pak-Leung Ho; Chung-Mau Lo; Kwok-Yung Yuen
Journal:  BMC Infect Dis       Date:  2014-09-23       Impact factor: 3.090

9.  Vancomycin-resistant Enterococcus faecium sequence type 796 - rapid international dissemination of a new epidemic clone.

Authors:  Andrew A Mahony; Andrew H Buultjens; Susan A Ballard; Elizabeth A Grabsch; Shirley Xie; Torsten Seemann; Rhonda L Stuart; Despina Kotsanas; Allen Cheng; Helen Heffernan; Sally A Roberts; Geoffrey W Coombs; Narin Bak; John K Ferguson; Glen C Carter; Benjamin P Howden; Timothy P Stinear; Paul D R Johnson
Journal:  Antimicrob Resist Infect Control       Date:  2018-03-22       Impact factor: 4.887

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.